Chad M. Cohen

Insider Reports History

Entity
Individual
Location
C/O Adaptive Biotechnologies Corporation, 1551 Eastlake Avenue E Ste 200, Seattle, WA
Signature
By: /s/ Rebecca Boyden, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chad M. Cohen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vacasa, Inc. Director Class A Common Stock 30.4K $279K $9.19 May 21, 2024 Direct
Adaptive Biotechnologies Corp Chief Financial Officer Common Stock 21.6K $89.2K $4.13 Dec 22, 2021 Direct
Adaptive Biotechnologies Corp Chief Financial Officer Stock Option (Right to Buy) 80K Dec 22, 2021 Direct

Insider Reports Filed by Chad M. Cohen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VCSA Vacasa, Inc. May 21, 2024 1 $0 4 May 23, 2024 Director
VCSA Vacasa, Inc. May 23, 2023 1 $0 4 May 24, 2023 Director
VCSA Vacasa, Inc. May 24, 2022 1 $0 4 May 25, 2022 Director
ADPT Adaptive Biotechnologies Corp Dec 22, 2021 3 -$227K 4 Dec 23, 2021 Chief Financial Officer
VCSA Vacasa, Inc. Dec 7, 2021 0 $0 3 Dec 7, 2021 Director
ADPT Adaptive Biotechnologies Corp Nov 9, 2021 6 -$277K 4 Nov 12, 2021 Chief Financial Officer
ADPT Adaptive Biotechnologies Corp Oct 5, 2021 6 -$251K 4 Oct 7, 2021 Chief Financial Officer
ADPT Adaptive Biotechnologies Corp Sep 7, 2021 6 -$470K 4 Sep 9, 2021 Chief Financial Officer
ADPT Adaptive Biotechnologies Corp Aug 10, 2021 7 -$413K 4 Aug 12, 2021 Chief Financial Officer
ADPT Adaptive Biotechnologies Corp Jul 6, 2021 7 -$643K 4 Jul 8, 2021 Chief Financial Officer
ADPT Adaptive Biotechnologies Corp Jun 8, 2021 7 -$596K 4 Jun 10, 2021 Chief Financial Officer
ADPT Adaptive Biotechnologies Corp May 11, 2021 7 -$511K 4 May 13, 2021 Chief Financial Officer